H. Lundbeck A/S
- Country
- 🇩🇰Denmark
- Ownership
- Public, Subsidiary
- Established
- 2000-01-01
- Employees
- 5.6K
- Market Cap
- -
- Website
- http://www.lundbeck.com
A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments
- First Posted Date
- 2020-06-05
- Last Posted Date
- 2023-09-29
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 892
- Registration Number
- NCT04418765
- Locations
- 🇬🇧
Panthera Biopartners - Manchester, Manchester, England, United Kingdom
🇩🇪Synexus - Leipzig, Leipzig, Sachsen, Germany
🇩🇪Neuroplus, Mannheim, Baden-Württemberg, Germany
Binding of Lu AG06466 in the Brain in Healthy Men
- First Posted Date
- 2020-06-05
- Last Posted Date
- 2021-02-24
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 16
- Registration Number
- NCT04419636
- Locations
- 🇧🇪
UZ Leuven campus Gasthuisberg, Leuven, Belgium
Study That Evaluates the Effect of CYP3A4 Inhibition on Lu AG06466 in Healthy Men and Women
- First Posted Date
- 2020-05-28
- Last Posted Date
- 2020-08-14
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 16
- Registration Number
- NCT04405323
- Locations
- 🇺🇸
US1517, Miami, Florida, United States
Eptinezumab in Healthy Japanese Subjects
- First Posted Date
- 2020-04-07
- Last Posted Date
- 2020-08-14
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 18
- Registration Number
- NCT04336449
- Locations
- 🇯🇵
P-One Clinic, Tokyo, Japan
Study Investigating Effects of Foliglurax in Patients With Parkinson's Disease (PD) and Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2020-03-26
- Last Posted Date
- 2020-07-07
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 6
- Registration Number
- NCT04322227
- Locations
- 🇫🇷
Biotrial Rennes, Rennes, France
Vortioxetine in Patients With Depression and Early Dementia
- First Posted Date
- 2020-03-04
- Last Posted Date
- 2022-08-08
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 82
- Registration Number
- NCT04294654
- Locations
- 🇫🇷
Centre de Recherche-Hopital Geriatrique de Charpennes, Villeurbanne, France
🇪🇪Marienthali Kliinik, Tallinn, Estonia
🇮🇹Azienda Ospedaliera di Perugia - Policlinico Monteluce, Perugia, Umbria, Italy
Lu AF28996 in Participants With Parkinson's Disease (PD)
- First Posted Date
- 2020-03-02
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 63
- Registration Number
- NCT04291859
- Locations
- 🇺🇸
Velocity, Hallandale Beach, Florida, United States
🇺🇸Atlanta Center for Medical Research, Atlanta, Georgia, United States
🇺🇸Inland Nortwest Research, Spokane, Washington, United States
Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in India
- First Posted Date
- 2020-02-28
- Last Posted Date
- 2022-03-18
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 400
- Registration Number
- NCT04288895
- Locations
- 🇮🇳
Vinaya Hospital & Research Centre (IN1007), Mangalore, Karnataka, India
🇮🇳BJ Medical College and Civil Hospital (IN028), Ahmedabad, Gujarat, India
🇮🇳Mangala Hospital & Mangala Kidney Foundation (IN1006), Mangalore, Karnataka, India
Effects of Repeated Doses of Foliglurax on Drug Metabolizing Enzymes in Healthy Subjects
- First Posted Date
- 2020-02-19
- Last Posted Date
- 2020-04-24
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 20
- Registration Number
- NCT04275115
- Locations
- 🇫🇷
Biotrial, Rennes, France
Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD)
- First Posted Date
- 2020-01-07
- Last Posted Date
- 2021-04-20
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 100
- Registration Number
- NCT04220996
- Locations
- 🇵🇱
Niepubliczny Zaklad Opieki Psychiatrycznej Mentis (PL0004), Leszno, Poland
🇵🇱Centrum Medyczne Luxmed Sp.Z O.O. (PL0006), Lublin, Poland
🇵🇱Clinical Research Center Spolka z ograniczona odpowiedzialnoscia Medic-R Sp.k. (PL0007), Poznan, Poland